Abstract:Objective: Cysteine-rich secretory protein 2 (CRISP2) is an important sperm protein and plays roles in spermatogenesis, modulation of flagellar motility, acrosome reaction, and gamete fusion. Clinical evidence shows a reduced CRISP2 expression in spermatozoa from asthenozoospermic patients, but the molecular mechanism underlying its reduction remains unknown. Herein, we carried out a study focusing on the CRISP2 reduction and its roles in asthenozoospermia. Methods: Spermatozoa were isolated from 90 study subjects’ ejaculated semen samples. DNA methylation was evaluated using bisulfite-sequencing PCR and methylation-specific PCR. The CRISP2 mRNA and protein expression levels were examined in the ejaculated spermatozoa by qRT-PCR and Western blot respectively. MiRNA expression was detected by qRT-PCR. The direct regulatory effect of miR-27b on CRISP2 was predicted computationally and validated via luciferase reporter assay and in vitro experiments in which miR-27b mimic or inhibitor was transfected into 293T cells. Respective correlations of miR-27b and CRISP2 protein expression with clinical features were analyzed using Spearman’s correlation coefficient. Results: Initially, low expression of CRISP2 protein rather than its mRNA was observed in the ejaculated spermatozoa from asthenozoospermic patients relative to normozoospermic males. Meanwhile, methylation was not found in CRISP2 promoter. These data suggest a possible post-transcriptional regulation of CRISP2 in asthenozoospermia. Subsequently, bioinformatics prediction, luciferase reporter assay and miR-27b transfection experiments revealed that miR-27b could specifically target CRISP2 by binding its 3’-UTR, suppressing CRISP2 expression post-transcriptionally. Further evidence was provided by the clinical observation of a high miR-27b expression in the ejaculated spermatozoa from asthenozoospermic patients and a negative correlation between miR-27b and CRISP2 protein expression. Finally, a retrospective follow-up study supported that both high miR-27b expression and low CRISP2 protein expression were associated with low sperm progressive motility, abnormal morphology and infertility. Conclusions: This study provides the first preliminary insight into the mechanism leading to the reduced CRISP2 expression in asthenozoospermia, offering a potential therapeutic target for treating male infertility or for male contraception.

Expression of Clusterin in Spermatozoa of Idiopathic Asthenozoospermic Men

Study on the expression of Clusterin in testis of infertility men

A Novel Splicing Variant in DNAH8 Causes Asthenozoospermia.

Low Expression of Glycoprotein Subunit 130 in Ejaculated Spermatozoa from Asthenozoospermic Men.

Comparative proteomic study between human normal motility sperm and idiopathic asthenozoospermia

[Expressions of zinc homeostasis proteins, GPR39 and ANO1 mRNA in the sperm of asthenozoospermia patients and their clinical significance]

Differential Expression of ODF1 in Human Ejaculated Spermatozoa and Its Clinical Significance

Down-regulation of DJ-1 Protein in the Ejaculated Spermatozoa from Chinese Asthenozoospermia Patients.

Chloride Channels Are Involved in Sperm Motility and Are Downregulated in Spermatozoa from Patients with Asthenozoospermia.

Differential Expression of GP130 in Ejaculated Spermatozoa from Healthy Volunteers and the Patients with Asthenospermia

Differential expression of Ropporin in ejaculated spermatozoa from health volunteers and the patients with asthenospermia

AB087. the Expression of Cysteine-Rich Secretory Protein 2 (CRISP2) and Its Specific Regulator Mir-27B in the Spermatozoa of Patients with Asthenozoospermia

Sperm motility inversely correlates with seminal leptin levels in idiopathic asthenozoospermia

Clusterin expression and distribution in spermatozoa as predictor of male fertility

The expression of the new epididymal luminal protein of PDZ domain containing 1 is decreased in asthenozoospermia.

Expression of PPP3CC and not PPP3R2 is associated with asthenozoospermia

Relationship between level of serum/seminal plasma leptin level and sperm motility in patients with idiopathic asthenospermia

RNASET2 in Human Spermatozoa and Seminal Plasma: a Novel Relevant Indicator for Asthenozoospermia

Expression of TRPC5 is Decreased in the Sperm of Patients with Varicocele-Associated Asthenozoospermia.

Study on differential expression of GRP78 between normal motility sperm protein and asthenospermia

Expression of NDUFA13 in Asthenozoospermia and Possible Pathogenesis.